Edition:
United States

Chemours Co (CC.N)

CC.N on New York Stock Exchange

48.04USD
15 Dec 2017
Change (% chg)

$0.55 (+1.16%)
Prev Close
$47.49
Open
$47.71
Day's High
$48.26
Day's Low
$47.44
Volume
1,552,714
Avg. Vol
607,854
52-wk High
$58.07
52-wk Low
$20.76

Select another date:

Fri, Dec 1 2017

BRIEF-Chemours Updates 2017 Forecast, Provides 2018 Outlook, 2020 Key Financial Targets

* CHEMOURS CO - BOARD OF DIRECTORS AUTHORIZED A $500 MILLION SHARE REPURCHASE PLAN

BRIEF-Greenlight Capital cuts share stake in Apple, General Motors

* Greenlight Capital cuts share stake in Apple Inc by 44.2 percent to 2.2 million shares - SEC filing

BRIEF-The Chemours Company reports third quarter results

* Q3 earnings per share view $1.04 -- Thomson Reuters I/B/E/S

BRIEF-UTR partners with Chemours to develop anode material

* Co ‍entered into agreement with Chemours to jointly develop anode material Source text for Eikon: Further company coverage:

Ex-Chemours employee accused by U.S. of trade secrets theft scheme

A former Chemours Co employee has been indicted on U.S. charges that he conspired to steal trade secrets related to its lucrative sodium cyanide business and sell them to Chinese investors, U.S. prosecutors said on Thursday.

Ex-Chemours employee accused by U.S. of trade secrets theft scheme

Oct 12 A former Chemours Co employee has been indicted on U.S. charges that he conspired to steal trade secrets related to its lucrative sodium cyanide business and monetize them with Chinese investors, U.S. prosecutors said on Thursday.

BRIEF-Chemours co - ‍ on Aug 4, co, E. I. du Pont de Nemours and company entered into an amendment to separation agreement

* Chemours Co - ‍ on Aug 4, co, E. I. du Pont de Nemours and company entered into an amendment to separation agreement, dated as of July 1, 2015​

BRIEF-Chemours responds to EPA 2015 ruling to regulate HFCs

* Company is currently reviewing court's ruling and assessing its options which could include an appeal of this ruling

BRIEF-The Chemours Company Q2 earnings per share $0.84

* The Chemours Company reports strong second quarter results and increases full-year 2017 outlook

BRIEF-Chemours sees 2017 adjusted EBITDA above $1.25 bln

* Chemours Co - sees 2017 adjusted EBITDA above $1.25 billion

Select another date: